Evidence map›Paper›PMID 31215821›Full record

ReviewSeminars in ophthalmology2019

Imaging the Corneal Endothelium in Fuchs Corneal Endothelial Dystrophy.

Stephan Ong Tone, Ula Jurkunas

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Guttae modifying effect following intracameral injection of magnetically delivered human corneal endothelial cells in Fuchs endothelial corneal dystrophy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  4. Article
  5. Review
  6. Longitudinal Study ofMedical sciences (Basel, Switzerland) · 2026
    Article
  7. Observational
  8. Article
  9. Article
  10. PortableBiomedical optics express · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Corneal injury repair and the potential involvement of ZEB1.Eye and vision (London, England) · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stephan Ong Tonea Schepens Eye Research Institute, Massachusetts Eye and Ear , Harvard Medical School , Boston , MA , USA.ORCID http://orcid.org/0000-0001-8619-1490
Ula Jurkunasa Schepens Eye Research Institute, Massachusetts Eye and Ear , Harvard Medical School , Boston , MA , USA.
Massachusetts Eye and Ear Infirmary · US

Funding

The Role of Oxidative Stress in the Pathogenesis of Fuchs Endothelial Corneal DysR01EY020581 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Ula V. Jurkunas · 2010 to 2026
$8.0M
NEI NIH HHS R01 EY020581
6 · The paper itself

Abstract

Fuchs endothelial corneal dystrophy (FECD) is characterized by the progressive degeneration of the corneal endothelium (CE). The purpose of this article is to review the diagnostic tools available to image and assess the CE in FECD. Slit-lamp biomicroscopy with specular reflection and retroillumination are important techniques to assess the CE. Objective diagnostic tests, such as retroillumination photographic analysis, specular microscopy,

Indexed as

Diagnostic Techniques, OphthalmologicalEndothelium, CornealFuchs' Endothelial DystrophyHumansMicroscopy, ConfocalSlit Lamp MicroscopyTomography, Optical CoherenceConfocalcorneaendotheliumFuchsspecular

Identifiers

PMID31215821
PMCPMC6629500
OpenAlexW2949812013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.